Bank of New York Mellon Corp Takes $2.38 Million Position in Ardent Health, Inc. $ARDT

Key Points

• Bank of New York Mellon opened a new Ardent Health position, purchasing 241,587 shares worth approximately $2.38 million, or about 0.17% of the company.
• Ardent Health reported quarterly EPS of $0.12, below the $0.18 analyst consensus, while revenue of $1.62 billion exceeded estimates of $1.59 billion. The company issued fiscal 2026 EPS guidance of $0.78–$1.15.
• Analyst sentiment is mixed: the consensus rating is “Hold” with a $13.05 price target, despite several firms raising targets to $13 and others downgrading the stock to “Strong Sell.”

Bank of New York Mellon Corp purchased a new stake in Ardent Health, Inc. (NYSE:ARDT - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 241,587 shares of the company's stock, valued at approximately $2,377,000. Bank of New York Mellon Corp owned approximately 0.17% of Ardent Health as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. The Manufacturers Life Insurance Company increased its holdings in shares of Ardent Health by 3.7% in the first quarter. The Manufacturers Life Insurance Company now owns 29,812 shares of the company's stock valued at $255,000 after purchasing an additional 1,072 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Ardent Health by 0.6% in the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company's stock worth $3,918,000 after acquiring an additional 1,769 shares during the last quarter. The Manufacturers Life Insurance Company increased its stake in shares of Ardent Health by 8.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 27,530 shares of the company's stock worth $376,000 after acquiring an additional 2,110 shares during the last quarter. Caitong International Asset Management Co. Ltd raised its stake in Ardent Health by 1,177.7% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company's stock worth $25,000 after purchasing an additional 2,638 shares during the period. Finally, Alliancebernstein L.P. lifted its holdings in Ardent Health by 24.8% in the third quarter. Alliancebernstein L.P. now owns 16,472 shares of the company's stock valued at $218,000 after acquiring an additional 3,272 shares during the last quarter.

Ardent Health Trading Down 0.3%

ARDT opened at $10.88 on Tuesday. The business has a fifty day moving average price of $10.72 and a 200 day moving average price of $9.82. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.10 and a quick ratio of 1.99. Ardent Health, Inc. has a 12 month low of $7.71 and a 12 month high of $15.48. The stock has a market capitalization of $1.53 billion, a price-to-earnings ratio of 19.78, a PEG ratio of 3.09 and a beta of 0.71.

Ardent Health (NYSE:ARDT - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.12 EPS for the quarter, missing analysts' consensus estimates of $0.18 by ($0.06). The company had revenue of $1.62 billion for the quarter, compared to analyst estimates of $1.59 billion. Ardent Health had a return on equity of 10.35% and a net margin of 1.22%.Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Sell-side analysts expect that Ardent Health, Inc. will post 0.96 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently issued reports on ARDT. Truist Financial boosted their price target on shares of Ardent Health from $12.00 to $13.00 and gave the company a "buy" rating in a research note on Thursday, August 6th. The Goldman Sachs Group reiterated a "neutral" rating and issued a $13.00 target price on shares of Ardent Health in a report on Thursday, August 6th. Royal Bank Of Canada boosted their target price on Ardent Health from $12.00 to $13.00 and gave the company an "outperform" rating in a research report on Monday, August 10th. Weiss Ratings cut Ardent Health from a "sell (d+)" rating to a "sell (d)" rating in a research note on Tuesday, August 11th. Finally, Zacks Research lowered Ardent Health from a "hold" rating to a "strong sell" rating in a research report on Thursday, August 6th. Seven equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $13.05.

Ardent Health Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company's integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.